These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8277513)

  • 21. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.
    Malmberg A; Nordvall G; Johansson AM; Mohell N; Hacksell U
    Mol Pharmacol; 1994 Aug; 46(2):299-312. PubMed ID: 8078492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1-Phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes and related derivatives as ligands for the neuromodulatory sigma 3 receptor: further structure-activity relationships.
    Wyrick SD; Booth RG; Myers AM; Owens CE; Bucholtz EC; Hooper PC; Kula NS; Baldessarini RJ; Mailman RB
    J Med Chem; 1995 Sep; 38(19):3857-64. PubMed ID: 7562917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]7-OH-DPAT labels both dopamine D3 receptors and sigma sites in the bovine caudate nucleus.
    Schoemaker H
    Eur J Pharmacol; 1993 Oct; 242(3):R1-2. PubMed ID: 8281986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors.
    Dutta AK; Venkataraman SK; Fei XS; Kolhatkar R; Zhang S; Reith ME
    Bioorg Med Chem; 2004 Aug; 12(16):4361-73. PubMed ID: 15265488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of dopamine D3 receptor binding by N-ethylmaleimide and neurotensin.
    Liu Y; Hillefors-Berglund M; von Euler G
    Brain Res; 1994 Apr; 643(1-2):343-8. PubMed ID: 7913398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors.
    Levant B; Grigoriadis DE; De Souza EB
    Eur J Pharmacol; 1995 May; 278(3):243-7. PubMed ID: 7589161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of the binding of dopamine D2/D3 receptor agonist, (R,S)-5-hydroxy-2-(N-propyl-N-(5'-(18)F-fluoropentyl)aminotetralin ((18)F-5-OH-FPPAT) in rodents and nonhuman primates.
    Shi B; Narayanan TK; Christian BT; Chattopadhyay S; Mukherjee J
    Nucl Med Biol; 2004 Apr; 31(3):303-11. PubMed ID: 15028242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior.
    Neisewander JL; Fuchs RA; Tran-Nguyen LT; Weber SM; Coffey GP; Joyce JN
    Neuropsychopharmacology; 2004 Aug; 29(8):1479-87. PubMed ID: 15100700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.
    Murray AM; Ryoo HL; Gurevich E; Joyce JN
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11271-5. PubMed ID: 7972046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligands.
    Watts VJ; Lawler CP; Knoerzer T; Mayleben MA; Neve KA; Nichols DE; Mailman RB
    Eur J Pharmacol; 1993 Aug; 239(1-3):271-3. PubMed ID: 8223910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
    MacKenzie RG; VanLeeuwen D; Pugsley TA; Shih YH; Demattos S; Tang L; Todd RD; O'Malley KL
    Eur J Pharmacol; 1994 Jan; 266(1):79-85. PubMed ID: 7907989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ligands of glutamate and dopamine receptors evenly labeled with hydrogen isotopes].
    Zolotarev IuA; Firstova IuIu; Abaimov DA; Dadaian AK; Kosik VS; Novikov AV; Krasnov NV; Vas'kovskiĭ BV; Nazimov IV; Kovalev GI; Miasoedov NF
    Bioorg Khim; 2009; 35(3):323-33. PubMed ID: 19621047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.
    Kung HF; Kasliwal R; Pan SG; Kung MP; Mach RH; Guo YZ
    J Med Chem; 1988 May; 31(5):1039-43. PubMed ID: 2966245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that dopamine D3 receptors participate in clozapine-induced hypothermia.
    Millan MJ; Audinot V; Melon C; Newman-Tancredi A
    Eur J Pharmacol; 1995 Jul; 280(2):225-9. PubMed ID: 7589191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin.
    Lévesque D; Diaz J; Pilon C; Martres MP; Giros B; Souil E; Schott D; Morgat JL; Schwartz JC; Sokoloff P
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8155-9. PubMed ID: 1518841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
    Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine D3-preferring ligands act at synthesis modulating autoreceptors.
    Aretha CW; Sinha A; Galloway MP
    J Pharmacol Exp Ther; 1995 Aug; 274(2):609-13. PubMed ID: 7636720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [125I](S)-trans-7-OH-PIPAT: a potential spect imaging agent for sigma binding sites.
    Garner SE; Kung MP; Foulon C; Chumpradit S; Kung HF
    Life Sci; 1994; 54(9):593-603. PubMed ID: 8114613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.